UC San Diego Health is the first hospital system in the region to provide a novel immunotherapy treatment approved by the U.S. Food and Drug Administration.
The treatment is an opportunity “to deliver leading-edge treatment to patients with advanced cancers that are underserved by current treatment modalities,” said Ayad Hamdan, MD, physician-in-chief at Moores Cancer Center.
